The Global Sepsis Diagnostics Market is growing with the rapid pace; mainly due to the increasing prevalence of Sepsis, Advent treatment facilities & Technological advancements. According to a recent study report published by the Market Research Future, The global market of Sepsis Diagnostics is booming and expected to gain prominence over the forecast period. The market is projected to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2016 – 2022). The global market for sepsis diagnostics is likely to reach USD 710 million by the end of the forecasted period and is expected to grow at a CAGR of 8%.
Augmented health concerns such as Cancer, Diabetes, Major Trauma, and Burns etc. are damaging the immune system among all age groups, which is fostering the demand for the Sepsis diagnostics market. Moreover, increasing surgical procedures, exponential rise in incidence of hospital-acquired infections and growth in the number of product approvals are supporting the growth of this market. Growing prevalence of hospital-acquired infections are also expected to support the growth of the market over the anticipated period. Hospital-acquired infections majorly include urinary tract & surgical site infections, which result into sepsis. According to WHO, 7 out of every 100 hospitalized patients develop hospital-acquired infections in developed countries. Therefore, such infections significantly cause septicaemia, which will resultantly raise the need for early diagnosis. On the other hand, pneumonia is also an important driving factor for high demand of sepsis diagnostics as it is one of the major causes for septic shock.
On the other hand, lack of standard protocols and awareness and shortage of skilled staff are the hindering the same.
Key Players are bioMérieux, Inc. (US), EKF Diagnostics (UK), Immunexpress (US), T2 Biosystems, Inc. (US), Becton, Dickinson and Company (US), Axis-Shield Diagnostics Ltd. (Scotland), Cube Dx GmbH (Austria), Sandstone Diagnostics, Inc. (US) are some of the prominent players profiled in MRFR Analysis and are at the forefront of competition in the Global Sepsis Diagnostics Market.
Sample Report Available at https://www.marketresearchfuture.com/sample_request/2110 .
Sepsis is a type of life-threatening organ dysfunction arises when the body’s response to an infection injures its own tissues and organs. It can be caused due to weakened immune system, chronic illness, kidney or liver disease, cancer and severe wounds. It can be of two types severe sepsis when there’s organ failure and other is septic shock in which there are the symptoms of severe sepsis includes a low blood pressure. The hospital-acquired infections and rising prevalence of sepsis has led to a growing need for its early diagnosis, which is one of the driving factor for sepsis diagnostics market.
Procalcitonin (PCT) is the biomarker of choice to aid diagnosis of sepsis. Procalcitonin is widely regarded as the most useful biomarker of severe systemic inflammation, infection and sepsis, offering emergency department and intensive care clinicians a key tool to aid the diagnosis of sepsis.
Sepsis Diagnostics Global Market – Competitive Analysis
Characterized by the presence of several major well-established players, the global Market of Sepsis Diagnostics appears to be highly competitive. Players operating in the global Sepsis Diagnostics markets are focusing upon optimized situational awareness for customers and ensure their mission success. Well established players increasingly seeking market expansion through various strategic mergers and acquisitions, innovation, increasing investments in research and development and cost-effective product portfolio. Strategic partnerships between Key players support the growth and expansion plans of the key players during the forecast period. These players possess state of art developing labs and strong sales and distribution network which have helped them to gain leadership position in the market. An ever-increasing emphasis has been observed among dental industry marketers on inbound lead generation over branding-oriented efforts.
Browse complete report at https://www.marketresearchfuture.com/reports/sepsis-diagnostics-market .
Sepsis Diagnostics Global Market – Regional Analysis
Globally North America is the largest market for medical tourism. The North American market for sepsis diagnostics is expected to reach USD 320 million by the end of the forecasted period.
Europe is the second largest market for sepsis diagnostics which is expected to grow at the CAGR of 6.8%. Asia Pacific is expected to be fastest growing region in sepsis diagnostics market.
Although, these countries markets are expected to be mature, the industry is likely to find stagnant growth for this market after few years. Increasing determination to provide best-in-class healthcare services with improvement in products and services will enhance the growth of this market. On the other hand, Asia Pacific region will be with China, India, Japan, Republic of Korea, Australia and others its forefront will lead the market further to next 7 years and will continue with this trend through the forecast period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312